Tags

Type your tag names separated by a space and hit enter

[Cannabinoids for neuropathic pain management].
Ugeskr Laeger 2018; 180(9)UL

Abstract

Pharmacological treatment of neuropathic pain is associated with side effects and limited efficacy. Recently, the interest in cannabis-based medicine has led to legalisation of medical cannabis in some countries. The aim of this review is to evaluate the evidence of cannabinoids in neuropathic pain. Seventeen trials were identified; eight reported an analgesic efficacy of cannabis-based medicine, and the remaining trials showed no analgesic efficacy. Conclusions were limited by design of studies and short duration of treatment. Overall, the reduction in pain was minimal.

Authors+Show Affiliations

lasse.oestergaard.andersen.01@regionh.dk.No affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Review

Language

dan

PubMed ID

29506645

Citation

Andersen, Lasse Østergaard, et al. "[Cannabinoids for Neuropathic Pain Management]." Ugeskrift for Laeger, vol. 180, no. 9, 2018.
Andersen LØ, Enggaard TP, Højsted J. [Cannabinoids for neuropathic pain management]. Ugeskr Laeg. 2018;180(9).
Andersen, L. Ø., Enggaard, T. P., & Højsted, J. (2018). [Cannabinoids for neuropathic pain management]. Ugeskrift for Laeger, 180(9).
Andersen LØ, Enggaard TP, Højsted J. [Cannabinoids for Neuropathic Pain Management]. Ugeskr Laeg. 2018 Feb 26;180(9) PubMed PMID: 29506645.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - [Cannabinoids for neuropathic pain management]. AU - Andersen,Lasse Østergaard, AU - Enggaard,Thomas Peter, AU - Højsted,Jette, PY - 2018/3/7/entrez PY - 2018/3/7/pubmed PY - 2019/3/16/medline JF - Ugeskrift for laeger JO - Ugeskr. Laeg. VL - 180 IS - 9 N2 - Pharmacological treatment of neuropathic pain is associated with side effects and limited efficacy. Recently, the interest in cannabis-based medicine has led to legalisation of medical cannabis in some countries. The aim of this review is to evaluate the evidence of cannabinoids in neuropathic pain. Seventeen trials were identified; eight reported an analgesic efficacy of cannabis-based medicine, and the remaining trials showed no analgesic efficacy. Conclusions were limited by design of studies and short duration of treatment. Overall, the reduction in pain was minimal. SN - 1603-6824 UR - https://www.unboundmedicine.com/medline/citation/29506645/[Cannabinoids_for_neuropathic_pain_management]_ L2 - http://ugeskriftet.dk/videnskab/V08170602 DB - PRIME DP - Unbound Medicine ER -